With effect from 1 June 2017, the following POMs were granted exemptions for limited sale and supply without prescription by the Health Sciences Authority (HSA).
This move is in line with HSA.’s efforts to further enhance access to effective and safe medicines by the general public.
These selected POMs had been reviewed by HSA. that they can be used in a safe and effective manner under the supervision of a pharmacist, subject to conditions including indication, strength, maximum daily dose, maximum supply quantity, and age restriction.
New POMs granted exemptions for limited sale and supply without prescription (with effect from 1 June 2017)
|
Active ingredient |
Exemptions for supply of POM without prescription |
|
As eyedrops not exceeding 0.25% Indication: Prevention of itching associated with allergic conjunctivitis Maximum daily dose: One drop into affected eye once daily Maximum supply: 3ml Minimum age: 3 years |
|
|
As eyedrops not exceeding 0.05% Indication: Short-term treatment of signs and symptoms of allergic conjunctivitis Maximum daily dose: One drop into the affected eye twice daily Maximum supply: 5ml Minimum age: 3 years |
|
|
As an oral liquid preparation not exceeding 6mg/ml Indications: For the symptomatic treatment of allergic rhinitis and chronic idiopathic urticarial Maximum daily dose: 60mg Maximum supply: 150ml Minimum age: 2 years |
|
|
As an intranasal spray not exceeding 27.5 mcg/actuation Indication: Prevention and treatment of allergic rhinitis Maximum daily dose: 110 mcg Maximum supply: 3 months Minimum age: 18 years |
|
|
As an oral solid preparation not exceeding 2mg Indications: Symptomatic treatment of allergic rhinitis and chronic urticaria Maximum daily dose: 2mg Maximum supply: 10 days Minimum age: 3 years As an oral liquid preparation not exceeding 1mg/5ml Indications: Symptomatic treatment of allergic rhinitis and chronic urticaria Maximum daily dose: 2mg Maximum supply: 120ml Minimum age: 3 years |
|
|
As a topical paste/lotion containing not more than 0.1% Indication: For the treatment of mouth ulcers |
In the absence of an appropriate consumer pack for the supply of medicines under this exemption, the Pharmaceutical Society of Singapore (PSS) has developed patient information leaflets (PILs) for pharmacists to supply upon dispensing.
The reclassification of medicines exercise has been a regular annual event to transition more medicines to a lower tier of control, so as to improve the accessibility of these medicines to the public.
For the full list of Updates on Reclassified Medicines, visit this link:
For the full list of PSS PILs, go to:
Prepared by: Sharene Goh
